- Volume is elevated versus the 13-week average, confirming attention.
- Latest weekly return ranks in the strongest part of its sector group.
S1RP34
SAO
Week ended 07 Aug 2026
Weekly Investor Report
Sarepta Therapeutics, Inc. · Healthcare · Biotechnology
Latest close
4.28 BRL
12.6%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -10.1% below the Trend Line and sits at 18.2% of its 52-week range. The latest completed week returned 12.6%, after a -12.1% four-week move. The latest news-sentiment score is 48/100.
Setup score
24
out of 100
Latest Close
4.28 BRL
7 Aug 2026
1W Return
12.6%
latest completed week
4W Return
-12.1%
short-term follow-through
12W Return
-10.1%
quarterly tape
Trend Breadth
9.6%
5 of 52 weeks active
Volume Ratio
1.8x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
12.6%
Latest completed week; four-week move -12.1%.
Indicator stack
5/22
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
48/100
10 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -10.1% below the Trend Line and sits at 18.2% of its 52-week range. The latest completed week returned 12.6%, after a -12.1% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.8x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0812-week average 0.18
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure8/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.08Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -12.1% over four weeks, -10.1% over 12 weeks, and -12.1% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year5
Trend breadth9.6%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.35Latest activity-pressure read.
Pressure change-271.1%Four-week change in activity pressure.
Leadership-19.88Latest relative-leadership reading.
RS change-50.7%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment48/100
Weighted news tone is neutral across 10 relevant articles.
0 positive · 9 neutral · 1 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-35.8%Distance below the 52-week high.
13-week volatility9.7%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher11 of 2615 weeks finished lower.
Best week+18.3%Week of 19 Jun.
Worst week-9.9%Week of 22 May.
Latest week+12.6%Week of 7 Aug.
Shape of recent returns
Strong gains5
Modest gains6
Flat weeks0
Modest losses5
Sharp losses10
Recent vol9.7%13-week weekly-return volatility.
Base vol9.5%52-week weekly-return volatility.
Up/down split25/26Count of positive and negative weeks in the 52-week window.
Average skew7.7% / -7.0%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorBR Healthcare
4-week rank72 / 82
Group average-0.7%
Trend breadth35.4%
Trend35.4%active weekly trend signals
MD65.9%positive activity pressure
RS46.3%positive relative leadership
Four-week leaders
IndustryBR Biotechnology
4-week rank10 / 13
Group average-2.5%
Trend breadth30.8%
Trend30.8%active weekly trend signals
MD61.5%positive activity pressure
RS53.8%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape24/100
Trend, activity pressure, participation, and risk combine to a 24/100 tape read.
Indicator analysis24/100Latest 12-week confirmation: trend 0/12, activity pressure 8/12, relative leadership 0/12.
Activity pressure 0.08; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment48/100Weighted news tone is neutral across 10 relevant articles.
Sarepta Sells Arrowhead Stake to Fund Milestone Payment Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 4.28 BRL | 12.6% | 4.76 BRL | 20.58 BRL | -0.35 | -19.88 | 8.7K | Off |
| 31 Jul 2026 | 3.80 BRL | -4.3% | 4.83 BRL | 20.71 BRL | -0.26 | -31.52 | 18.7K | Off |
| 24 Jul 2026 | 3.97 BRL | -9.8% | 4.89 BRL | 20.85 BRL | -0.10 | -27.37 | 379 | Off |
| 17 Jul 2026 | 4.40 BRL | -9.7% | 4.96 BRL | 20.98 BRL | 0.10 | -19.46 | 5.0K | Off |
| 10 Jul 2026 | 4.87 BRL | -3.0% | 5.01 BRL | 21.12 BRL | 0.20 | -13.19 | 18.9K | Off |
| 3 Jul 2026 | 5.02 BRL | 15.4% | 5.04 BRL | 21.26 BRL | 0.01 | -9.19 | 0 | Off |
| 26 Jun 2026 | 4.35 BRL | -5.0% | 5.08 BRL | 21.40 BRL | -0.02 | -21.14 | 3.6K | Off |
| 19 Jun 2026 | 4.58 BRL | 18.3% | 5.12 BRL | 21.55 BRL | 0.08 | -15.12 | 2 | Off |
| 12 Jun 2026 | 3.87 BRL | -8.5% | 5.13 BRL | 21.69 BRL | 0.16 | -29.91 | 4 | Off |
| 5 Jun 2026 | 4.23 BRL | -5.2% | 5.17 BRL | 21.87 BRL | 0.44 | -24.70 | 4 | Off |
| 29 May 2026 | 4.46 BRL | 4.0% | 5.18 BRL | 22.04 BRL | 0.64 | -25.55 | 2.1K | Off |
| 22 May 2026 | 4.29 BRL | -9.9% | 5.24 BRL | 22.21 BRL | 0.66 | -31.38 | 3.9K | Off |
| 15 May 2026 | 4.76 BRL | -6.7% | 5.30 BRL | 22.39 BRL | 0.64 | -26.48 | 1.5K | Off |
| 8 May 2026 | 5.10 BRL | -2.9% | 5.35 BRL | 22.59 BRL | 0.53 | -26.02 | 11.7K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.